Immunic, Inc.
IMUX
$1.12
-$0.03-2.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.31% | -13.98% | 27.73% | -37.14% | 5.26% |
| Total Depreciation and Amortization | -16.67% | 35.48% | 19.23% | 13.04% | -32.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.12% | 40.93% | -85.43% | 560.87% | -16.44% |
| Change in Net Operating Assets | -95.44% | -46.73% | 173.31% | -165.65% | 64.62% |
| Cash from Operations | -10.38% | -22.15% | 28.95% | -70.88% | 18.98% |
| Capital Expenditure | 94.00% | 72.22% | -480.65% | 81.21% | -275.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 94.00% | 72.22% | -480.65% | 81.21% | -275.00% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -68.38% | 114.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | 12,228.48% | 114.18% |
| Foreign Exchange rate Adjustments | -327.43% | 156.08% | -331.61% | -69.63% | 207.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.46% | -17.11% | -134.78% | 489.07% | 26.07% |